A Study Evaluating the Effect of Botulinum Toxin Type A on Semen Quality in Patients With Benign Prostatic Hyperplasia.
Phase of Trial: Phase I/II
Latest Information Update: 27 Sep 2013
At a glance
- Drugs Botulinum toxin A (Primary)
- Indications Benign prostatic hyperplasia
- Focus Pharmacodynamics
- 31 Aug 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 19 Mar 2012 Actual patient number (61) added as reported by ClinicalTrials.gov.
- 19 Mar 2012 Planned End Date changed from 1 Jun 2013 to 1 Sep 2012 as reported by ClinicalTrials.gov.